Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  03/11/2005
 
Trade Name:  Xopenex HFA Inhalation Aerosol
 
Generic Name or Proper Name (*):  levalbuterol
 
Indications Studied:  Treatment of bronchospasm in patients with reversible obstructive airway disease in children 4 years of age and older
 
Label Changes Summary:  Extended indication for use in children down from 6 years of age Pediatric patients have a lower exposure to the drug than adults Population PK model developed from patients down to 4 years of age Effectiveness and safety established from studies in adults, adolescents (12 years of age and older) and children ages 4-11 years of age with asthma. Deferred studies in patients < 4 years of age New active ingredient
 
Product Labeling:  Labeling  Opens a new window
 
PREA(P):  P
 
Sponsor:  Sepracor
 
NNPS:  FALSE'
 
Therapeutic Category:  Antiasthmatic
 
-
-